The government slapped a prominent, though confusing, warning on the popular diabetes drug Avandiatelling patients that it may, or may not, increase the risk of heart attacks. The move is less stringent than steps Canada took to restrict the drugs use to hard-to-treat diabetics. But the U.S. Food and Drug Administration concluded that studies are too contradictory to tell if Avandia really is riskier than other treatments for Type 2 diabetes. FULL STORY
Diabetes drug to warn of risk to heart
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.